APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/dxn-holdings-bhd" target="_blank" data-smartkarma-citation="entities:36030:1" rel="noopener">DXN Holdings (2080694D MK)</a> is looking to raise around US$159m in its Malaysia IPO.</li>
<li>DXN Holdings (DXN) is a global health-oriented and wellness direct selling company.</li>
<li>In our previous note, we looked at the company’s past performance. In this note, we take a look at the company’s updated financials.</li>
</ul>



DXN Holdings (2080694D MK) is looking to raise around US$159m in its Malaysia IPO.
DXN Holdings (DXN) is a global health-oriented and wellness direct selling company.
In our previous note, we looked at the company’s past performance. In this note, we take a look at the company’s updated financials.


DXN Holdings IPO - Updates Since Our Last Note

<ul>
<li>
<a href="https://www.smartkarma.com/entities/dxn-holdings-bhd" target="_blank" data-smartkarma-citation="entities:36030:1" rel="noopener">DXN Holdings (2080694D MK)</a> is looking to raise up to US$200m in its upcoming Malaysia IPO.</li>
<li>DXN Holdings (DXN) is a global health-oriented and wellness direct selling company.</li>
<li>In this note, we will talk about the not-so-positive aspects of the deal.</li>
</ul>



DXN Holdings (2080694D MK) is looking to raise up to US$200m in its upcoming Malaysia IPO.
DXN Holdings (DXN) is a global health-oriented and wellness direct selling company.
In this note, we will talk about the not-so-positive aspects of the deal.


DXN Holdings Pre-IPO - The Negatives - Profits Weakened over Track Period. Past Regulatory Run-Ins

<ul>
<li>
<a href="https://www.smartkarma.com/entities/dxn-holdings-bhd" target="_blank" data-smartkarma-citation="entities:36030:1" rel="noopener">DXN Holdings (2080694D MK)</a> is looking to raise up to US$200m in its upcoming Malaysia IPO.</li>
<li>DXN Holdings (DXN) is a global health-oriented and wellness direct selling company.</li>
<li>In this note, we will talk about the positive aspects of the deal.</li>
</ul>



DXN Holdings (2080694D MK) is looking to raise up to US$200m in its upcoming Malaysia IPO.
DXN Holdings (DXN) is a global health-oriented and wellness direct selling company.
In this note, we will talk about the positive aspects of the deal.


DXN Holdings Pre-IPO - The Positives - Diverse and Growing Portfolio. Strong Long-Term Record

Research Firm with a Qualitative Overlay, Pearl Gray Equity and Research

Pearl Gray Equity and Research

Research Firm with a Qualitative Overlay

Quantitative fund & research firm with a qualitative overlay. 

Our coverage: General U.S. with a skew towards the primary sector. 

Methods: Smart Beta/Factor Pricing, Neural Networks, Street Gossip, and Common Sense.

Equity Bottom-Up

Nu Skin Enterprises Inc A / Equity Bottom-Up

<ul>
<li>The skincare industry is likely slowing and Nu Skin's affiliate business model is no longer generating growth.</li>
<li>The company's inventory build-up has tapered, meaning it likely expects softer demand.</li>
<li>The stock could be a value trap as growth is forecasted to slow, which could compress its price multiples.</li>
</ul>


The skincare industry is likely slowing and Nu Skin's affiliate business model is no longer generating growth.
The company's inventory build-up has tapered, meaning it likely expects softer demand.
The stock could be a value trap as growth is forecasted to slow, which could compress its price multiples.


Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

iShares Russell 2000 ETF / Technical Analysis

<ul>
<li>The market continues to send mixed signals - some neutral or healthy signals but some risk-off signals as well.</li>
<li>As long as the Russell 2000 index (IWM) is above $208, Russell Micro Cap index (IWC) is above $134-$135, and the S&amp;P 500 is above 4495, we cannot be bearish.</li>
<li>Treasury yields are not breaking down below 1.40%-1.45% support on the 10-year Treasury yield and 1.76% support on the 30-year Treasury yield.</li>
</ul>


The market continues to send mixed signals - some neutral or healthy signals but some risk-off signals as well.
As long as the Russell 2000 index (IWM) is above $208, Russell Micro Cap index (IWC) is above $134-$135, and the S&amp;P 500 is above 4495, we cannot be bearish.
Treasury yields are not breaking down below 1.40%-1.45% support on the 10-year Treasury yield and 1.76% support on the 30-year Treasury yield.


Continued Absence Of Breakdowns Is A Positive Sign; Many Bottoms-Up Stock Recommendations

United States

Nu Skin Enterprises, Inc. is a global direct selling company.  The Company distributes premium quality personal care products and nutritional supplements. Nu Skin markets its products in the Americas, Europe, and the Asia Pacific region.  The Company provides marketing and distribution of technology-based products through Big Planet, Inc.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Nu Skin Enterprises Inc A (NUS US)

DXN Holdings IPO - Updates Since Our Last Note

DXN Holdings (2080694D MK) is looking to raise around US$159m in its Malaysia IPO. DXN Holdings (DXN) is a global health-oriented and wellness...

Clarence Chu

DXN Holdings Pre-IPO - The Negatives - Profits Weakened over Track Period. Past Regulatory Run-Ins

DXN Holdings (2080694D MK) is looking to raise up to US$200m in its upcoming Malaysia IPO. In this note, we will talk about the not-so-positive...

Clarence Chu

DXN Holdings Pre-IPO - The Positives - Diverse and Growing Portfolio. Strong Long-Term Record

DXN Holdings (2080694D MK) is looking to raise up to US$200m in its upcoming Malaysia IPO. In this note, we will talk about the positive aspects of...

Clarence Chu

Nu Skin: Sell On The Pullback

Nu Skin's weak year-to-date performance is due to a culmination of factors that stem from both systemic and idiosyncratic events

Pearl Gray Equity and Research

Continued Absence Of Breakdowns Is A Positive Sign; Many Bottoms-Up Stock Recommendations

As long as the Russell 2000 index (IWM) is above $208, the Russell Micro Caps index (IWC) is above $134-$135, and the S&P 500 is above 4495, we...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)